Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
0.6622
+0.0200 (3.11%)
At close: Aug 24, 2026, 4:00 PM EDT
0.6678
+0.0056 (0.85%)
After-hours: Aug 24, 2026, 7:47 PM EDT

Humacyte Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
184185650294218747
Market Cap Growth
-28.74%-71.47%120.90%35.19%-70.86%471.21%
Enterprise Value
17121770925197549
Last Close Price
0.640.965.052.842.117.25

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
86.5690.96--139.03591.27
PB Ratio
5.7159.63-12.3421.721.866.11
P/TBV Ratio
5.8759.63-21.721.866.11

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
80.42106.41--61.82434.31

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
2.1421.02-1.554.290.430.42
Net Debt / Equity Ratio
-0.424.78-0.70-1.65-0.87-1.43
Net Debt / EBITDA Ratio
0.13-0.15-0.340.251.332.39
Net Debt / FCF Ratio
0.13-0.14-0.370.301.402.14
Asset Turnover
0.020.02--0.010.01
Quick Ratio
5.372.772.254.367.7620.42
Current Ratio
6.213.692.404.517.8820.76
Return on Equity (ROE)
-547.87%---169.81%-10.01%-27.46%
Return on Assets (ROA)
-49.87%-52.82%-53.74%-36.44%-21.54%-25.81%
Return on Capital Employed (ROCE)
-89.70%-109.60%-97.00%-88.30%-45.80%-29.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-52.65%-22.03%-22.88%-37.66%-5.50%-3.55%
FCF Yield
-53.14%-57.14%-15.34%-25.70%-33.17%-10.90%
Buyback Yield / Dilution
-45.78%-33.49%-14.56%-0.36%-157.82%-593.25%
SEC Filings: 10-K · 10-Q